| miR-203 |
M. bovis BCG |
MyD88 |
Inhibits production of NF-κB, TNF-α, and IL-6 |
(101) |
| miR-149 |
M. bovis BCG |
MyD88 |
Reduced production of NF-κB, TNF-α, and IL-6 |
(103) |
| miR-124 |
M. bovis BCG |
TLR6, MyD88, TRAF-6, TNF-α |
Blocks inflammatory response |
(96) |
| miR-31 and miR-150 |
M. bovis BCG |
MyD88 |
Interferes with TLR2 signalling |
(101,102) |
| miR-142-3p |
M. bovis BCG |
IRAK-1 |
NF- κB, TNF-α, and IL-6 |
(91) |
| miR-146a |
M. bovis BCG |
IRAK-1 and TRAF-6 |
Reduces activation of NF-κB and MAPK signalling, PTGS2, suppresses NO production |
(97) |
| miR-146a |
M. bovis BCG |
IFN-γ |
Autoimmune disease involving STAT1 pathway |
(113) |
| miR-21 |
M. bovis BCG |
IL-12p35 mRNA |
Inhibits IL-12 production |
(105) |
| miR-155 |
M. marium |
CEBP |
Inhibits production NO synthase |
(69) |
| Let-7a and miR-29a |
M. avium |
Caspase 3 and 7 |
Inhibition of apoptosis |
(10) |
| miR-142-3p |
M. smegmatis |
N-WASP |
Deregulation of actin dynamics during phagocytosis |
(91) |
| miR-125b |
M. smegmatis |
TNF |
Inhibition of TNF-α, IL-6, IL-12, and IL-1 production |
(58) |
| miR-21 |
M. leprae |
CAMP, DEFB4 |
Inhibition of vitamin D dependent anti-microbial pathway |
(118) |
